Literature DB >> 7487496

In vitro synthesis of foot-and-mouth disease virus specific antibodies by porcine leukocytes.

A Rodríguez1, J C Sáiz, F Sobrino.   

Abstract

We have characterized the in vitro secondary antibody response to FMDV of peripheral blood mononuclear cells (PBMC) from immunized pigs. The results obtained indicated that primed swine leukocytes can support an in vitro T-B cell cooperation which is functional and leads to the production of viral specific antibodies. The response was shown to be independent of viral replication, being induced by both infective and inactivated virus as well as by recombinant polypeptides VP1 and VP3. In all cases, concentration of PBMC supernatants allowed the detection of viral-specific IgG antibodies by ELISA. Significant titers of foot-and-mouth disease virus (FMDV) specific neutralizing antibodies were detected in concentrated supernatants after stimulation with either infective or inactivated whole virus, whereas no neutralizing activity was found in supernatants from PBMC responding to individual capsid polypeptides. The titers of IgG1 and IgG2 were similar for PBMC incubated with viruses, while IgG2 predominated when VP1 or VP3 were used as stimulators. In addition, significant titers of IFN-gamma were detected in supernatants of PBMC stimulated with infectious or chemically inactivated FMDV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487496     DOI: 10.1007/bf01322538

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  24 in total

1.  A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle.

Authors:  T Collen; R Dimarchi; T R Doel
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

Review 2.  Cell biology of antigen presentation.

Authors:  J J Neefjes; F Momburg
Journal:  Curr Opin Immunol       Date:  1993-02       Impact factor: 7.486

3.  Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants.

Authors:  M J Francis; G Z Hastings; A D Syred; B McGinn; F Brown; D J Rowlands
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

Review 4.  T cell-dependent B cell activation.

Authors:  D C Parker
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 5.  Mechanism and regulation of immunoglobulin isotype switching.

Authors:  R L Coffman; D A Lebman; P Rothman
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

6.  Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites.

Authors:  P V Barnett; E J Ouldridge; D J Rowlands; F Brown; N R Parry
Journal:  J Gen Virol       Date:  1989-06       Impact factor: 3.891

7.  Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus.

Authors:  G Mulcahy; C Gale; P Robertson; S Iyisan; R D DiMarchi; T R Doel
Journal:  Vaccine       Date:  1990-06       Impact factor: 3.641

8.  Ammonium sulfate fractionation of sera: mouse, hamster, guinea pig, monkey, chimpanzee, swine, chicken, and cattle.

Authors:  G A Hebert
Journal:  Appl Microbiol       Date:  1974-02

9.  Induction of antibody to foot-and-mouth disease virus in presensitized mouse spleen cell cultures.

Authors:  T Collen; K C McCullough; T R Doel
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

10.  Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.

Authors:  M J van Lierop; K van Maanen; R H Meloen; V P Rutten; M A de Jong; E J Hensen
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

View more
  1 in total

1.  Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus.

Authors:  E Blanco; M Garcia-Briones; A Sanz-Parra; P Gomes; E De Oliveira; M L Valero; D Andreu; V Ley; F Sobrino
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.